Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:AMIX NASDAQ:MBAI NASDAQ:SINT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.78+14.7%$0.74$0.23▼$3.42$11.69M-0.181.88 million shs21,644 shsAMIXAutonomix Medical$0.35-8.5%$0.40$0.32▼$2.64$2.64M-1.82148,120 shs127,212 shsMBAICheck-Cap$1.45-2.7%$1.67$0.59▼$3.92$10.86M0.57131,230 shs22,578 shsSINTSintx Technologies$2.35-1.7%$2.62$1.99▼$6.78$9.85M0.6147,753 shs7,627 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%-0.64%-12.14%-39.64%-71.49%AMIXAutonomix Medical0.00%+12.44%-3.68%-4.02%-78.87%MBAICheck-Cap0.00%+1.36%-9.15%-10.24%+148,999,900.00%SINTSintx Technologies0.00%+13.27%-11.48%-18.71%-4.40%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.78+14.7%$0.74$0.23▼$3.42$11.69M-0.181.88 million shs21,644 shsAMIXAutonomix Medical$0.35-8.5%$0.40$0.32▼$2.64$2.64M-1.82148,120 shs127,212 shsMBAICheck-Cap$1.45-2.7%$1.67$0.59▼$3.92$10.86M0.57131,230 shs22,578 shsSINTSintx Technologies$2.35-1.7%$2.62$1.99▼$6.78$9.85M0.6147,753 shs7,627 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%-0.64%-12.14%-39.64%-71.49%AMIXAutonomix Medical0.00%+12.44%-3.68%-4.02%-78.87%MBAICheck-Cap0.00%+1.36%-9.15%-10.24%+148,999,900.00%SINTSintx Technologies0.00%+13.27%-11.48%-18.71%-4.40%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.00Hold$3.00284.66% UpsideAMIXAutonomix Medical 2.00Hold$2.00471.43% UpsideMBAICheck-Cap 1.00SellN/AN/ASINTSintx Technologies 2.33Hold$11.00368.09% UpsideCurrent Analyst Ratings BreakdownLatest AMIX, MBAI, ALUR, and SINT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/4/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)4/24/2026MBAICheck-Cap Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026SINTSintx Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026SINTSintx Technologies HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$10.004/8/2026SINTSintx Technologies Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $12.002/24/2026ALURAllurion Technologies Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetNeutral ➝ Buy$2.50 ➝ $3.002/24/2026ALURAllurion Technologies Loop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$3.002/17/2026AMIXAutonomix Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$5.00 ➝ $2.00(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$17.21M0.68N/AN/A($30.08) per share-0.03AMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/AMBAICheck-CapN/AN/A$0.55 per share2.62$0.47 per shareN/ASINTSintx Technologies$1.02M9.49N/AN/A$0.80 per share2.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$7.20M-$10.56N/AN/AN/A-199.96%N/A-77.13%5/13/2026 (Estimated)AMIXAutonomix Medical-$11.41M-$3.55N/AN/AN/AN/A-228.82%-186.65%6/4/2026 (Estimated)MBAICheck-Cap$4.14M-$2.77N/AN/AN/AN/AN/AN/AN/ASINTSintx Technologies-$10.36M-$5.66N/AN/AN/A-1,018.08%-242.76%-99.86%5/15/2026 (Estimated)Latest AMIX, MBAI, ALUR, and SINT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2026N/AAMIXAutonomix Medical-$0.26N/AN/AN/AN/AN/A5/15/2026N/ASINTSintx Technologies-$0.66N/AN/AN/A$0.30 millionN/A5/13/2026Q1 2026ALURAllurion Technologies-$0.34N/AN/AN/A$3.10 millionN/A2/11/2026Q3 2026AMIXAutonomix Medical-$0.46-$0.36+$0.10-$0.36N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AAMIXAutonomix MedicalN/AN/AN/AN/AN/AMBAICheck-CapN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A1.260.94AMIXAutonomix MedicalN/A6.186.18MBAICheck-CapN/A0.050.05SINTSintx TechnologiesN/A1.511.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%AMIXAutonomix Medical10.78%MBAICheck-Cap1.07%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies8.10%AMIXAutonomix Medical6.20%MBAICheck-Cap0.48%SINTSintx Technologies4.08%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies50114.99 million11.28 millionNo DataAMIXAutonomix Medical16.91 million6.48 millionN/AMBAICheck-Cap807.29 million7.25 millionN/ASINTSintx Technologies404.12 million3.95 millionNot OptionableAMIX, MBAI, ALUR, and SINT HeadlinesRecent News About These CompaniesSintx Technologies (SINT) Projected to Post Quarterly Earnings on FridayMay 8 at 1:30 AM | americanbankingnews.comSintx Technologies (SINT) price target decreased by 25.00% to 12.24April 15, 2026 | msn.comHC Wainwright & Co. initiates coverage of Sintx Technologies (SINT) with buy recommendationApril 13, 2026 | msn.comSINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial ExecutionMarch 23, 2026 | globenewswire.comSINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle ImplantMarch 19, 2026 | globenewswire.comSintx Technologies (NASDAQ:SINT) Director Purchases $21,848.60 in StockMarch 11, 2026 | insidertrades.comSINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterialsMarch 2, 2026 | voxelmatters.comVSINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial PlatformsFebruary 18, 2026 | globenewswire.comSINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5January 29, 2026 | markets.businessinsider.comSINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5January 29, 2026 | globenewswire.comSintx Technologies (SINT) price target decreased by 36.00% to 16.32December 21, 2025 | msn.comInsider Buying: Sintx Technologies (NASDAQ:SINT) CIO Buys 8,200 Shares of StockDecember 10, 2025 | insidertrades.comSintx Technologies (NASDAQ:SINT) CIO Gregg Honigblum Acquires 65,000 SharesDecember 9, 2025 | insidertrades.comAscendiant Capital maintains Sintx Technologies (SINT) buy recommendationDecember 8, 2025 | msn.comSINTX Technologies to Participate in Sidoti & Company Investor ConferenceDecember 8, 2025 | markets.businessinsider.comSINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific ImplantsDecember 1, 2025 | globenewswire.comSINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational EfficienciesNovember 13, 2025 | markets.businessinsider.comInsider Buying: Sintx Technologies (NASDAQ:SINT) CIO Acquires 10,000 Shares of StockNovember 11, 2025 | insidertrades.comSINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge SystemNovember 3, 2025 | globenewswire.comSintx Technologies (SINT) Price Target Decreased by 10.71% to 25.50October 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMIX, MBAI, ALUR, and SINT Company DescriptionsAllurion Technologies NYSE:ALUR$0.78 +0.10 (+14.71%) As of 05/8/2026 03:59 PM EasternAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Autonomix Medical NASDAQ:AMIX$0.35 -0.03 (-8.47%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$0.36 +0.01 (+1.43%) As of 05/8/2026 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Check-Cap NASDAQ:MBAI$1.45 -0.04 (-2.68%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$1.48 +0.03 (+2.00%) As of 05/8/2026 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.Sintx Technologies NASDAQ:SINT$2.35 -0.04 (-1.67%) Closing price 05/8/2026 04:00 PM EasternExtended Trading$2.36 +0.00 (+0.21%) As of 05/8/2026 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/04 - 05/08 SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
